Ruypeptide Biotechnology Co., Ltd.** is expanding its international presence by strengthening its biotechnology research capabilities, manufacturing capacity, and global customer support as demand for ...

Jubilant Biosys, an integrated drug discovery and development partner, convened the 2nd EDGE Innovation Forum in San Diego on ...

The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech-friendly ...

SAN FRANCISCO--(BUSINESS WIRE)--As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18 th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology ...

A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...

As the work of the Pharmaceutical and Life Sciences Sector Task Force (Task Force) comes to a close, we welcome the report published today and thank the Task Force for its thoughtful discussions on ...

This article is authored by Dhananjay Singh, managing director, Merck Life Science & head, Discovery Solutions, India.

Biopharmaceutical innovation has traditionally been difficult to capture through market exposures. This article explores how ...

CPIC 2026 opens in Shanghai on July 22. [Photo provided to chinadaily.com.cn] Global pharmaceutical leaders convened in ...

Germany-headquartered science and technology giant Merck will continue to deepen its presence in China's healthcare sector, ...

This $120 million investment is modeled after the American NIH, and it will accelerate the timeline from lab discovery to ...

New initiative under NSG Bio Tomorrow will support promising startups developing next-generation approaches in respiratory and neonatal care ...